Trial site
Re:Cognition Health - Chicago
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Alcohol use disorder2 trials
- Epilepsy1 trial
- Opioid use disorder1 trial
- Schizophrenia1 trial
- Phase
- Phase 36 trials
- Phase 23 trials
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- AriBio Co., Ltd.1 trial
- Bristol-Myers Squibb1 trial
- Ono Pharmaceutical Co., Ltd.1 trial
- Rapport Therapeutics Inc.1 trial
Running trials
Recruiting
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
Recruiting
A Study of Brenipatide in Participants With Alcohol Use Disorder
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Epilepsy1 recruiting
- Opioid use disorder1 recruiting
- Schizophrenia1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026